{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:52:49Z","timestamp":1761893569705},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1998,3,1]],"date-time":"1998-03-01T00:00:00Z","timestamp":888710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"vor","delay-in-days":8030,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1998,3]]},"DOI":"10.1023\/a:1008283909959","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T08:47:34Z","timestamp":1040546854000},"page":"289-295","source":"Crossref","is-referenced-by-count":71,"title":["Favorable outcome of patients with relapsed or refractory Hodgkin\u2019s disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional salvage therapy (Dexa-BEAM)"],"prefix":"10.1016","volume":"9","author":[{"given":"A.","family":"Josting","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"K\u00e0tay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Rueffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Tesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Engert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Diehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.D.","family":"Wickramanayake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008283909959_bb0010","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1200\/JCO.1992.10.2.210","article-title":"Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin\u2019s disease after combination chemotherapy: The low probability of cure","volume":"10","author":"Longo","year":"1992","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"10.1023\/A:1008283909959_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/annonc\/2.suppl_1.1","article-title":"Is there an effective salvage therapy for advanced Hodgkin\u2019s disease?","volume":"2","author":"Cannellos","year":"1991","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008283909959_bb0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1200\/JCO.1992.10.2.175","article-title":"The second chance for advanced Hodgkin\u2019s disease","volume":"10","author":"Cannellos","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008283909959_bb0025","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0002-9343(87)90766-2","article-title":"Salvage therapy of advanced Hodgkin\u2019s disease: Critical appraisal of curative potential","volume":"83","author":"Buzaid","year":"1987","journal-title":"Am J Med"},{"issue":"1","key":"10.1023\/A:1008283909959_bb0030","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1182\/blood.V83.5.1161.1161","article-title":"Autologous transplantation for Hodgkin\u2019s disease: Coming of Age?","volume":"5","author":"Biermann","year":"1994","journal-title":"Blood"},{"key":"10.1023\/A:1008283909959_bb0035","series-title":"High-Dose Cancer Therapy. Pharmacology, Hematopoietins, Stem Cells","first-page":"651","article-title":"Autologous bone marrow transplantation for Hodgkin\u2019s disease","author":"Vose","year":"1992"},{"issue":"10","key":"10.1023\/A:1008283909959_bb0040","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1200\/JCO.1991.9.10.1871","article-title":"Intensive chemotherapy with cyclophosphamide, carmustine and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin\u2019s disease","volume":"9","author":"Reece","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008283909959_bb0045","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/oxfordjournals.annonc.a058662","article-title":"High-dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin\u2019s disease\u2019 Long term follow-up in 128 patients","volume":"4","author":"Biermann","year":"1993","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1023\/A:1008283909959_bb0050","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1182\/blood.V83.5.1193.1193","article-title":"Intensive therapy with cyclophosphamide, carmustine, etoposide + \/ \u2013 cisplatin, and autologous bone marrow transplantation for Hodgkin\u2019s disease in first relapse after combination chemotherapy","volume":"83","author":"Reece","year":"1994","journal-title":"Blood"},{"key":"10.1023\/A:1008283909959_bb0055","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.1990.8.3.527","article-title":"High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin\u2019s disease","volume":"8","author":"Jones","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008283909959_bb0060","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0002-9343(91)90213-H","article-title":"Autologous bone marrow transplantation for patients with relapsed Hodgkin\u2019s disease","volume":"91","author":"Armitage","year":"1991","journal-title":"Am J Med"},{"key":"10.1023\/A:1008283909959_bb0065","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/oxfordjournals.annonc.a058043","article-title":"Prolonged disease-free survival after high-dose sequential chemo-radiotherapy and haematopoietic autologous transplantation in poor prognosis Hodgkin\u2019s disease","volume":"2","author":"Gianni","year":"1991","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1023\/A:1008283909959_bb0070","first-page":"1137","article-title":"The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin\u2019s disease. A single-center eight-year study of 155 patients","volume":"5","author":"Chopra","year":"1993","journal-title":"Bood"},{"issue":"4","key":"10.1023\/A:1008283909959_bb0075","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1200\/JCO.1993.11.4.704","article-title":"High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin\u2019s disease: Importance of disease status at transplant","volume":"11","author":"Crump","year":"1993","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1023\/A:1008283909959_bb0080","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1200\/JCO.1993.11.12.2351","article-title":"One hundred auto-transplants for relapsed or refractory Hodgkin\u2019s disease and lymphoma: Value of pretransplant disease status for predicting outcome","volume":"11","author":"Rappoport","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008283909959_bb0085","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1200\/JCO.1993.11.6.1062","article-title":"Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin\u2019s disease","volume":"11","author":"Yahalom","year":"1993","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1023\/A:1008283909959_bb0090","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1182\/blood.V73.1.340.340","article-title":"Successful treatment of refractory\u2019 Hodgkin\u2019s disease by high-dose combination chemotherapy and autologous bone marrow transplantation","volume":"73","author":"Gribben","year":"1989","journal-title":"Blood"},{"key":"10.1023\/A:1008283909959_bb0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.7326\/0003-4819-104-2-163","article-title":"High-dose cyclophosphamide, carmustine and etoposide and autologous bone marrow transplantation for relapsed Hodgkin\u2019s disease","volume":"104","author":"Jagannath","year":"1986","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1023\/A:1008283909959_bb0100","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1182\/blood.V73.8.2086.2086","article-title":"Treatment of progressive Hodgkin\u2019s disease with intensive chemoradiotherapy and autologous bone marrow transplantation","volume":"73","author":"Phillips","year":"1989","journal-title":"Blood"},{"key":"10.1023\/A:1008283909959_bb0105","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1200\/JCO.1988.6.9.1411","article-title":"High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin\u2019s disease patients: An Italian study group report","volume":"6","author":"Carella","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008283909959_bb0110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1182\/blood.V36.4.507.507","article-title":"Technique for human marrow grafting","volume":"36","author":"Thomas","year":"1970","journal-title":"Blood"},{"issue":"1","key":"10.1023\/A:1008283909959_bb0115","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V77.11.2322.bloodjournal77112322","article-title":"High-dose cyclophosphamide, carmustine and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin\u2019s disease","volume":"11","author":"Kessinger","year":"1991","journal-title":"Blood"},{"issue":"5","key":"10.1023\/A:1008283909959_bb0120","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1182\/blood.V85.5.1381.bloodjournal8551381","volume":"85","author":"Nademanee","year":"1995","journal-title":"Blood"},{"key":"10.1023\/A:1008283909959_bb0125","first-page":"431","article-title":"Treatment of refractory lymphoma with high-dose cytarabine, cyclophosphamide and either TBI or VP-16 followed by autologous bone marrow transplantation","volume":"5","author":"Broun","year":"1990","journal-title":"BMT"},{"issue":"15","key":"10.1023\/A:1008283909959_bb0130","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood.V77.10.2292.2292","article-title":"Outcome of treatment of first relapse of Hodgkin\u2019s disease after primary chemotherapy: Identification of risk factors from the British Columbia Experience 1970 to 1988","volume":"10","author":"Lohri","year":"1991","journal-title":"Blood"},{"key":"10.1023\/A:1008283909959_bb0135","first-page":"1203","volume":"71","author":"Pfreundschuh","year":"1987","journal-title":"Cancer Treat Rep"},{"key":"10.1023\/A:1008283909959_bb0140","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.1987.5.4.556","article-title":"MIME chemotherapy (methyl-GAG, ifosphamide, methotrexate, etoposide) as treatment for recurrent Hodgkin\u2019s disease","volume":"5","author":"Hagemeister","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008283909959_bb0145","first-page":"665","article-title":"Rozman C","volume":"70","author":"Cervantes","year":"1989","journal-title":"Treatment of advanced resistant Hodgkin\u2019s disease with lomustine. etoposide and prednimustine. Cancer Treat Rep"},{"key":"10.1023\/A:1008283909959_bb0150","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0140-6736(93)92411-L","article-title":"Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin\u2019s disease: Results of a BNLI randomized trial","volume":"341","author":"Linch","year":"1993","journal-title":"Lancet"},{"key":"10.1023\/A:1008283909959_bb0155","first-page":"19","article-title":"High-dose potentially myeloablative chemotherapy and autologous bone marrow transplantation for patients with advanced Hodgkin\u2019s disease","volume":"3","author":"Ahmed","year":"1989","journal-title":"Leukemia"},{"key":"10.1023\/A:1008283909959_bb0160","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/mpo.2950180603","article-title":"Treatment of refractory and relapsed Hodgkin\u2019s disease: Intensive chemotherapy and autologous bone marrow or peripheral blood stem cell support","volume":"18","author":"Hurd","year":"1990","journal-title":"Med Pediatr Oncol"},{"issue":"2","key":"10.1023\/A:1008283909959_bb0165","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1200\/JCO.1989.7.2.179","article-title":"Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin\u2019s disease","volume":"7","author":"Jagannath","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008283909959_bb0170","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/1097-0142(19830515)51:10<1773::AID-CNCR2820511002>3.0.CO;2-T","article-title":"Stepwise progress in the treatment of disseminated cancers","volume":"51","author":"Skipper","year":"1983","journal-title":"Cancer"},{"key":"10.1023\/A:1008283909959_bb0175","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1182\/blood.V77.12.2591.2591","article-title":"Identification and comparison of CD34 positive cells and their subpopulations from normal peripheral blood and bone marrow using flow cytometry","volume":"77","author":"Bender","year":"1991","journal-title":"Blood"},{"key":"10.1023\/A:1008283909959_bb0180","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1172\/JCI111645","article-title":"Single cell origin of multi-lineage colonies in culture","volume":"84","author":"Leary","year":"1984","journal-title":"J Cin Invest"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341955311X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341955311X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/9\/3\/289\/19481731\/9-3-289.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T19:16:25Z","timestamp":1582571785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341955311X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,3]]}},"alternative-id":["S092375341955311X"],"URL":"https:\/\/doi.org\/10.1023\/a:1008283909959","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1998,3]]}}}